dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Li, Na |
dc.contributor.author | Zethoven, Magnus |
dc.contributor.author | McInerny, Simone |
dc.contributor.author | Devereux, Lisa |
dc.contributor.author | Huang, Yu-Kuan |
dc.contributor.author | Thio, Niko |
dc.contributor.author | Gutierrez Enriquez, Sara |
dc.contributor.author | Moles Fernandez, Alejandro |
dc.contributor.author | Diez Gibert, Orland |
dc.date.accessioned | 2022-01-12T17:00:02Z |
dc.date.available | 2022-01-12T17:00:02Z |
dc.date.issued | 2021-04-12 |
dc.identifier.citation | Li N, Zethoven M, McInerny S, Devereux L, Huang YK, Thio N, et al. Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects. NPJ Breast Cancer. 2021 Apr 12;7:52. |
dc.identifier.issn | 2374-4677 |
dc.identifier.uri | https://hdl.handle.net/11351/6767 |
dc.description | Càncer de mama; Genètica del càncer; Mutació |
dc.language.iso | eng |
dc.publisher | Nature Research |
dc.relation.ispartofseries | npj Breast Cancer;7 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer - Prognosi |
dc.subject | Diàtesi |
dc.subject | Malalties congènites |
dc.subject.mesh | Breast Neoplasms |
dc.subject.mesh | /diagnosis |
dc.subject.mesh | Genetic Predisposition to Disease |
dc.title | Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41523-021-00255-3 |
dc.subject.decs | neoplasias de la mama |
dc.subject.decs | /diagnóstico |
dc.subject.decs | predisposición genética a la enfermedad |
dc.relation.publishversion | https://doi.org/10.1038/s41523-021-00255-3 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Li N] Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic, Australia. Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Vic, Australia. [Zethoven M] Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia. Bioinformatics Core Facility, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia. [McInerny S] Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Vic, Australia. [Devereux L] Lifepool, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia. [Huang YK] Upper Gastrointestinal Translational Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia. Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Melbourne, Vic, Australia. [Thio N] Bioinformatics Core Facility, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia. [Gutiérrez-Enríquez S, Moles-Fernández A] Hereditary Cancer Genetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Diez O] Hereditary Cancer Genetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Àrea de Genètica Clínica i Molecular, Hospital Universitari Vall d’Hebron, Barcelona, Spain |
dc.identifier.pmid | 33980861 |
dc.identifier.wos | 000656954400001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F01218 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F01303 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/CP16%2F00034 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |